CERSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
CERUS CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$2.22+0.04 (+1.83%)
Close on Oct 19, 2026
- Market cap
- $445.25M
- P/E (TTM)
- –
- Dividend yield
- –
CERUS CORP revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product | $206.13M | $180.27M | $156.37M | $162.05M | $130.86M | $91.92M | $74.65M | $60.91M | $43.57M | $37.18M | 88.2% | +14.3% |
| Government Contract | $27.67M | $21.05M | $30.43M | $26.27M | $28.66M | $22.33M | $19.13M | $15.14M | $7.76M | $2.09M | 11.8% | +31.4% |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Switzerland | – | – | – | – | – | – | – | – | – | $3.32M | – | – |
| France | – | – | – | – | – | – | – | – | $9.69M | $3.49M | – | – |
| Spain | – | – | – | – | – | – | – | – | $3.43M | $3.36M | – | – |
| Belgium | – | – | – | – | – | – | – | – | $6.26M | $6.39M | – | – |
| CIS | – | – | – | – | – | – | – | – | – | $2.86M | – | – |
| United States | – | – | – | – | – | – | – | – | $6.32M | $4.48M | – | – |
| Kuwait | – | – | – | – | – | – | – | – | $2.79M | $4.42M | – | – |
| Other Countries | – | – | – | – | – | – | – | – | $15.08M | $15.05M | – | – |
From the segment and revenue-disaggregation notes of Cerus's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.